JP2012524910A - 免疫調節物質の同定方法及びシステム - Google Patents

免疫調節物質の同定方法及びシステム Download PDF

Info

Publication number
JP2012524910A
JP2012524910A JP2012507451A JP2012507451A JP2012524910A JP 2012524910 A JP2012524910 A JP 2012524910A JP 2012507451 A JP2012507451 A JP 2012507451A JP 2012507451 A JP2012507451 A JP 2012507451A JP 2012524910 A JP2012524910 A JP 2012524910A
Authority
JP
Japan
Prior art keywords
expression
cells
cell
inflammatory
foxp3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012507451A
Other languages
English (en)
Japanese (ja)
Inventor
エル ラウンド ジュン
シェン ユー
ケイ マズマニアン サーキス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
California Institute of Technology
Original Assignee
California Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by California Institute of Technology filed Critical California Institute of Technology
Publication of JP2012524910A publication Critical patent/JP2012524910A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/101—Bovine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2012507451A 2009-04-23 2010-04-23 免疫調節物質の同定方法及びシステム Pending JP2012524910A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17210109P 2009-04-23 2009-04-23
US61/172,101 2009-04-23
PCT/US2010/032300 WO2010124256A2 (en) 2009-04-23 2010-04-23 Methods and systems for identifying immunomodulatory substances

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015116494A Division JP2016014660A (ja) 2009-04-23 2015-06-09 免疫調節物質の同定方法及びシステム

Publications (1)

Publication Number Publication Date
JP2012524910A true JP2012524910A (ja) 2012-10-18

Family

ID=42993293

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012507451A Pending JP2012524910A (ja) 2009-04-23 2010-04-23 免疫調節物質の同定方法及びシステム
JP2015116494A Pending JP2016014660A (ja) 2009-04-23 2015-06-09 免疫調節物質の同定方法及びシステム

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015116494A Pending JP2016014660A (ja) 2009-04-23 2015-06-09 免疫調節物質の同定方法及びシステム

Country Status (4)

Country Link
US (2) US20100275282A1 (enExample)
EP (1) EP2422200A4 (enExample)
JP (2) JP2012524910A (enExample)
WO (1) WO2010124256A2 (enExample)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013523838A (ja) * 2010-04-07 2013-06-17 シェン，ユエ 粘膜へ化合物を送るための媒体、それに関連する組成物、方法、及びシステム
US9539281B2 (en) 2011-07-12 2017-01-10 The Brigham And Women's Hospital, Inc. Lipid-containing PSA compositions, methods of isolation and methods of use thereof
JP2019054752A (ja) * 2017-09-21 2019-04-11 光博 岡野 口腔細菌叢中の構成叢比を予測する方法
US10857177B2 (en) 2015-08-19 2020-12-08 President And Fellows Of Harvard College Lipidated PSA compositions and methods
US11103566B2 (en) 2010-05-20 2021-08-31 California Institute Of Technology Antigen specific Tregs and related compositions, methods and systems
US11331335B2 (en) 2015-06-10 2022-05-17 California Institute Of Technology Sepsis treatment and related compositions methods and systems
US11491181B2 (en) 2016-07-15 2022-11-08 President And Fellows Of Harvard College Glycolipid compositions and methods of use
US11622973B2 (en) 2007-11-09 2023-04-11 California Institute Of Technology Immunomodulating compounds and related compositions and methods

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
WO2011151941A1 (ja) 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
US20130064859A1 (en) * 2011-01-28 2013-03-14 Sarkis K. Mazmanian Combinatorial vitamin d and probiotic therapy for inflammatory bowel disease
WO2013019896A1 (en) * 2011-08-01 2013-02-07 Symbiotix Biotherapies, Inc. Platform for identifying and/or characterizing immunomodulatory agents
EP2764090B1 (en) 2011-10-03 2017-12-13 California Institute of Technology Generation of psa-only producing mutant strain
CA2892588A1 (en) 2011-12-01 2013-06-06 School Corporation, Azabu Veterinary Medicine Educational Institution Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
WO2014182966A1 (en) 2013-05-10 2014-11-13 California Institute Of Technology Probiotic prevention and treatment of colon cancer
DK3347030T3 (da) 2015-09-10 2021-08-09 Univ Catholique Louvain Brug af pasteuriseret akkermansia til behandling af stofskiftesygdomme
WO2018023088A1 (en) 2016-07-29 2018-02-01 Confer Health, Inc. Gel electrophoresis diagnostic kit and methods of using the same
CA3048210A1 (en) 2016-12-23 2018-06-28 Vital Biosciences, Inc. Electrophoresis diagnostic methods and kits

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003204796A (ja) * 2001-11-08 2003-07-22 Japan Science & Technology Corp 非ヒト遺伝子改変動物およびその利用
WO2003095606A2 (en) * 2002-05-14 2003-11-20 Institut National de la Santé et de la Recherche Médicale A t cell subpopulation regulating gut immunity
WO2005010215A2 (en) * 2003-07-17 2005-02-03 Tolerrx, Inc. Methods for identifying tolerance modulatory compounds and uses therefor
WO2005094571A1 (ja) * 2004-03-31 2005-10-13 Japan Science And Technology Agency 遺伝子改変ヘテロ動物及び該動物を用いたエキソサイトシスの計測方法
JP2007119414A (ja) * 2005-10-31 2007-05-17 Univ Nagoya Ｃｄ８＋ｃｄ１２２＋ｔ細胞の免疫抑制活性を増強させる免疫抑制剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5679654A (en) * 1994-09-02 1997-10-21 Brigham & Women's Hospital, Inc. Capsular polysaccharide immunomodulator
US5700787A (en) * 1994-09-02 1997-12-23 Brigham & Women's Hospital, Inc. Capsular polysaccharide immunomodulator
US7083777B1 (en) * 1999-04-02 2006-08-01 The Brigham And Women's Hospital, Inc. Immunomodulating polymers
SV2003000753A (es) * 2000-12-05 2003-06-16 Brigham & Womens Hospital Uso de polisacaridos zwitterionicos para la especifica modulacion del progreso inmunologico
EP1372706B1 (en) * 2001-03-09 2010-12-01 ID Biomedical Corporation of Quebec Proteosome-liposaccharide vaccine adjuvant
CA2508720A1 (en) * 2002-12-03 2004-06-17 Dartmouth College Method to measure a t cell response and its uses to qualify antigen-presenting cells
AU2004227852B2 (en) * 2003-03-31 2010-01-14 The Brigham And Women's Hospital, Inc. Zwitterionic immunomodulators for the treatment of asthma and allergy
US8426146B2 (en) * 2005-06-03 2013-04-23 University of Pittsburgh—of the Commonwealth System of Higher Education Multiparameteric method for assessing immune system status
WO2007092451A2 (en) * 2006-02-06 2007-08-16 The Brigham And Women's Hospital, Inc. Zwitterionic polysaccharides for promotion of immune system maturation and health
EP2165194A4 (en) * 2007-05-31 2010-09-08 Abbott Lab BIOMARKERS FOR PREDICTING RESPONSABILITY TO TNF ALPHA INHIBITORS IN AUTOIMMUNE DISEASES

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003204796A (ja) * 2001-11-08 2003-07-22 Japan Science & Technology Corp 非ヒト遺伝子改変動物およびその利用
WO2003095606A2 (en) * 2002-05-14 2003-11-20 Institut National de la Santé et de la Recherche Médicale A t cell subpopulation regulating gut immunity
WO2005010215A2 (en) * 2003-07-17 2005-02-03 Tolerrx, Inc. Methods for identifying tolerance modulatory compounds and uses therefor
WO2005094571A1 (ja) * 2004-03-31 2005-10-13 Japan Science And Technology Agency 遺伝子改変ヘテロ動物及び該動物を用いたエキソサイトシスの計測方法
JP2007119414A (ja) * 2005-10-31 2007-05-17 Univ Nagoya Ｃｄ８＋ｃｄ１２２＋ｔ細胞の免疫抑制活性を増強させる免疫抑制剤

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN6014004504; Ｌｉｓｂｅｔｈ　Ｎ．　Ｆｉｎｋ　ｅｔ　ａｌ．: 'Ｈｕｍａｎ　ａｎｔｉｇｅｎ-ｐｒｅｓｅｎｔｉｎｇ　ｃｅｌｌｓ　ｒｅｓｐｏｎｄ　ｄｉｆｆｅｒｅｎｔｌｙ　ｔｏ　ｇｕｔ-ｄｅｒｉｖｅｄ　ｐｒｏｂｉｏｔｉｃ　ｂａｃｔｅｒｉａ　ｂｕｔｍｅｄｉａｔｅ　ｓｉｍｉ' ＦＥＭＳ　Ｉｍｍｕｎｏｌｏｇｙ　＆　Ｍｅｄｉｃａｌ　Ｍｉｃｒｏｂｉｏｌｏｇｙ Ｖｏｌｕｍｅ　５１，　Ｉｓｓｕｅ　３, 2007, ５３５-５４６ *
JPN6014004505; Ｈｅｒｍｅｌｉｊｎ　Ｈ．　Ｓｍｉｔｓ　ｅｔ　ａｌ．: 'Ｓｅｌｅｃｔｉｖｅ　ｐｒｏｂｉｏｔｉｃ　ｂａｃｔｅｒｉａ　ｉｎｄｕｃｅ　ＩＬ-１０-ｐｒｏｄｕｃｉｎｇ　ｒｅｇｕｌａｔｏｒｙ　Ｔ　ｃｅｌｌｓ　ｉｎ　ｖｉｔｒｏ　ｂｙ　ｍｏｄｕｌａｔｉｎｇ　ｄｅｎｄｒｉ' Ｊｏｕｒｎａｌ　ｏｆ　Ａｌｌｅｒｇｙ　ａｎｄ　Ｃｌｉｎｉｃａｌ　Ｉｍｍｕｎｏｌｏｇｙ Ｖｏｌｕｍｅ　１１５，　Ｉｓｓｕｅ　６, 2005, １２６０-１２６７ *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11622973B2 (en) 2007-11-09 2023-04-11 California Institute Of Technology Immunomodulating compounds and related compositions and methods
JP2013523838A (ja) * 2010-04-07 2013-06-17 シェン，ユエ 粘膜へ化合物を送るための媒体、それに関連する組成物、方法、及びシステム
JP2017014201A (ja) * 2010-04-07 2017-01-19 シェン, ユエSHEN, Yue 粘膜へ化合物を送るための媒体、それに関連する組成物、方法、及びシステム
JP2018109016A (ja) * 2010-04-07 2018-07-12 ザ カリフォルニア インスティテュート オブ テクノロジー 粘膜へ化合物を送るための媒体、それに関連する組成物、方法、及びシステム
US11419887B2 (en) 2010-04-07 2022-08-23 California Institute Of Technology Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems
US11103566B2 (en) 2010-05-20 2021-08-31 California Institute Of Technology Antigen specific Tregs and related compositions, methods and systems
US9539281B2 (en) 2011-07-12 2017-01-10 The Brigham And Women's Hospital, Inc. Lipid-containing PSA compositions, methods of isolation and methods of use thereof
US11331335B2 (en) 2015-06-10 2022-05-17 California Institute Of Technology Sepsis treatment and related compositions methods and systems
US10857177B2 (en) 2015-08-19 2020-12-08 President And Fellows Of Harvard College Lipidated PSA compositions and methods
US11491181B2 (en) 2016-07-15 2022-11-08 President And Fellows Of Harvard College Glycolipid compositions and methods of use
JP2019054752A (ja) * 2017-09-21 2019-04-11 光博 岡野 口腔細菌叢中の構成叢比を予測する方法

Also Published As

Publication number Publication date
US20100275282A1 (en) 2010-10-28
WO2010124256A3 (en) 2011-03-31
EP2422200A4 (en) 2013-02-27
US20170003274A1 (en) 2017-01-05
EP2422200A2 (en) 2012-02-29
JP2016014660A (ja) 2016-01-28
WO2010124256A2 (en) 2010-10-28

Similar Documents

Publication Publication Date Title
JP2016014660A (ja) 免疫調節物質の同定方法及びシステム
JP6674971B2 (ja) 粘膜へ化合物を送るための媒体、それに関連する組成物、方法、及びシステム
Shen et al. Outer membrane vesicles of a human commensal mediate immune regulation and disease protection
Kuczma et al. Commensal epitopes drive differentiation of colonic Tregs
CN104768560A (zh) 孤独症谱系障碍的诊断和治疗
CN110352236A (zh) 诱导Th1细胞的细菌
CN106497854B (zh) 乳杆菌d8及其应用
US20210386819A1 (en) Bioengineered lactobacillus probiotics and the uses thereof
Yap et al. In vitro treatment of lipopolysaccharide increases invasion of Pasteurella multocida serotype B: 2 into bovine aortic endothelial cells
EP4619753A1 (en) Novel reagents for the diagnosis and monitoring of food allergies and methods of use thereof
US20150196634A1 (en) Cultured myeloid dendritic cells isolated from peyers patches and uses thereof
Tóth Phagocytic efficiency of human monocyte-derived dendritic cells is affected by the peptidoglycan modifications in Lactobacillus casei BL23 and tumor-derived soluble factors
Balasubramanian Paneth cell-microbiota crosstalk orchestrates intestinal homeostasis
Shen Interkingdom communication of a bacterial mutualist and its mammalian host
HK40079872A (en) Diagnosis and treatment of autism spectrum disorder
Campbell An Atopic Microbiota Mediates Intestinal Inflammation through TLR4 Signaling
Lee et al. Dual Oxygen-Partitioned Co-Culture Uncovers Microbe-Specific Epithelial Stress and Homeostatic Programs
Han Inflammasome signalling and its impact on intestinal mucosal defense
Tóth et al. THESIS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY (PHD)
Bernardo et al. Microbiota sensing by mincle-syk axis in dendritic cells regulates interleukin-17 and-22 production and promotes intestinal barrier integrity
Yap SengKar et al. In vitro treatment of lipopolysaccharide increases invasion of Pasteurella multocida serotype B: 2 into bovine aortic endothelial cells.
Landy Studies of the aetiopathogenesis of pouchitis
MarıaMartınez-Lopez et al. ArticleMicrobiota Sensing by Mincle-Syk Axis in Dendritic Cells Regulates Interleukin-17 and-22 Production and Promotes Intestinal Barrier IntegrityGraphical AbstractHighlightsd Mincle detects mucosal commensals and triggers IL-6 and IL-23p19 in PPs d LysoDC and CD11b+ DC from PPs prime a microbiota-and
Zaki Activation of mucosal Th-17 cells in human nasopharynx-associated lymphoid tissue by Staphylococcus aureus and S. pneumoniae
Memory Specific CD4-pylori Helicobacter

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130418

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20140130

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140212

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140509

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140516

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140609

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140616

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140707

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140714

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140807

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150210